Form 4: Carrie Brownstein, Director at Shattuck Labs, Reports Stock Option Grant

Director Carrie Brownstein reports the acquisition of stock options in Shattuck Labs.

Summary

• Carrie Brownstein, a director at Shattuck Labs, filed a Form 4 with the SEC.
• The filing reports the grant of stock options to purchase 27,700 shares of Shattuck Labs common stock.
• The options were granted on June 21, 2024, with an exercise price of $4.37 per share.
• The options vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer.
• The options expire on June 21, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management interests with shareholders.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service to the company.

Industry Context

Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with those of shareholders and incentivizing long-term value creation.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the director to work towards increasing shareholder value.

Key Dates